当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析 - 现金流量表

华北制药

(600812)

  

流通市值:79.27亿  总市值:79.27亿
流通股本:17.16亿   总股本:17.16亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,144,049,246.961,436,562,723.527,527,509,548.095,427,084,311.73
  收到的税费返还61,366,537.8935,986,090.2145,071,333.8124,236,162.8
  收到其他与经营活动有关的现金109,390,578.7428,853,511.67167,204,666.3289,955,535.29
  经营活动现金流入小计3,314,806,363.591,501,402,325.397,839,785,548.215,641,276,009.82
  购买商品、接受劳务支付的现金1,412,147,764.21681,682,711.953,628,506,307.492,616,723,420.8
  支付给职工以及为职工支付的现金636,246,550.09326,122,616.791,346,365,383.19960,271,911.27
  支付的各项税费248,151,278.4122,265,813.92489,651,459.12359,758,331.02
  支付其他与经营活动有关的现金467,447,630.08212,665,026.321,198,723,142.411,043,076,468.39
  经营活动现金流出小计2,763,993,222.781,342,736,168.986,663,246,292.214,979,830,131.48
  经营活动产生的现金流量净额550,813,140.81158,666,156.411,176,539,256661,445,878.34
二、投资活动产生的现金流量:
  取得投资收益收到的现金--60,468,966.1560,293,032.8
  处置固定资产、无形资产和其他长期资产收回的现金净额111,20040,200615,026.21303,200
  收到的其他与投资活动有关的现金94,900,800---
  投资活动现金流入小计95,012,00040,20061,083,992.3660,596,232.8
  购建固定资产、无形资产和其他长期资产支付的现金256,271,661.75122,790,203.99542,012,200.76380,002,187.69
  投资支付的现金--300,000,000300,000,000
  投资活动现金流出小计256,271,661.75122,790,203.99842,012,200.76680,002,187.69
  投资活动产生的现金流量净额-161,259,661.75-122,750,003.99-780,928,208.4-619,405,954.89
三、筹资活动产生的现金流量:
  吸收投资收到的现金--385,000,000205,000,000
  其中:子公司吸收少数股东投资收到的现金--380,000,000-
  取得借款收到的现金7,708,358,0003,983,598,0008,777,750,0005,835,360,000
  收到其他与筹资活动有关的现金200,000,000-1,650,000,0001,020,000,000
  筹资活动现金流入小计7,908,358,0003,983,598,00010,812,750,0007,060,360,000
  偿还债务支付的现金7,757,813,988.943,963,436,872.289,146,239,928.665,713,875,623.1
  分配股利、利润或偿付利息支付的现金254,020,240.8472,482,112.84479,672,439.18391,711,985.74
  其中:子公司支付给少数股东的股利、利润47,690,370.96-66,830,370.9666,830,370.96
  支付其他与筹资活动有关的现金734,895,517.02284,667,947.641,572,101,962.131,087,423,793.36
  筹资活动现金流出小计8,746,729,746.84,320,586,932.7611,198,014,329.977,193,011,402.2
  筹资活动产生的现金流量净额-838,371,746.8-336,988,932.76-385,264,329.97-132,651,402.2
四、汇率变动对现金及现金等价物的影响-11,699,627.56-5,914,930.01477,331.533,040,427.58
五、现金及现金等价物净增加额-460,517,895.3-306,987,710.3510,824,049.16-87,571,051.17
  加:期初现金及现金等价物余额1,273,228,002.181,273,228,002.181,262,403,953.021,262,403,953.02
  期末现金及现金等价物余额812,710,106.88966,240,291.831,273,228,002.181,174,832,901.85
补充资料:
  净利润90,872,547.55-257,453,101.84-
  资产减值准备-6,650,965.62--17,226,881.24-
  固定资产和投资性房地产折旧344,058,266.12-652,528,855.33-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧344,058,266.12-652,528,855.33-
  无形资产摊销142,213,418.09-241,809,700.87-
  长期待摊费用摊销8,556,374.96-14,569,081.94-
  处置固定资产、无形资产和其他长期资产的损失-217,802.15--827,335.68-
  固定资产报废损失---32.19-
  财务费用151,511,629.14-361,548,158.82-
  投资损失-31,632,214.99--60,625,000.37-
  递延所得税-2,502,710.25--5,268,853.1-
  其中:递延所得税资产减少-2,502,710.25-23,283,851.89-
    递延所得税负债增加---28,552,704.99-
  存货的减少-54,232,202.07-118,902,218.35-
  经营性应收项目的减少-157,979,127.61--197,849,078.66-
  经营性应付项目的增加45,366,572.87--283,443,368.66-
  现金的期末余额812,710,106.88-1,273,228,002.18-
  减:现金的期初余额1,273,228,002.18-1,262,403,953.02-
  现金及现金等价物的净增加额-460,517,895.3-10,824,049.16-
公告日期2026-08-222026-04-252026-04-182025-10-25
审计意见(境内)标准无保留意见
TOP↑